Changzhou Qianhong Biopharma CO.,LTD (002550.SZ)
CNY 6.36
(0.47%)
CNY 6.36
(0.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 528.94 Million | -71.47 Million | 103.56 Million | 317.27 Million | 161.54 Million | 25.44 Million |
| Net Income | 181.86 Million | 319.91 Million | 186.34 Million | -147.62 Million | 256.91 Million | 211.04 Million |
| Depreciation & Amortization | 72.96 Million | 64.76 Million | 69.43 Million | 70.25 Million | 65.47 Million | 61.4 Million |
| Deferred income taxes | 10.51 Million | 2.42 Million | 6.07 Million | -69.22 Million | -17.14 Million | -3.72 Million |
| Stock-based compensation | 1.97 Million | 4.37 Million | 4.12 Million | 4.06 Million | 2.07 Million | 2.15 Million |
| Change in working capital | 292.31 Million | -382.73 Million | -109.99 Million | -9.91 Million | -109.12 Million | -140.16 Million |
| Other non-cash items | -175.09 Million | -80.21 Million | -52.4 Million | 469.72 Million | -36.63 Million | -106.84 Million |
| Investing Cash Flow | -134.02 Million | -189.97 Million | 95.28 Million | 459.53 Million | 185.02 Million | 290.75 Million |
| Investments in PPE | -100.33 Million | -70.98 Million | -90.37 Million | -62.53 Million | -100.67 Million | -103.53 Million |
| Acquisitions | 74.8 Million | -1.66 Million | 2638.84 | 15.68 Thousand | 1.7 Million | 2.98 Million |
| Investment purchases | -266.3 Million | -155.2 Million | -39.82 Million | -10.2 Million | -6.34 Million | -1.54 Billion |
| Sales/Maturities of investments | 157.8 Million | 37.43 Million | 8.43 Million | 32.16 Million | 93.77 Million | 134.4 Million |
| Other Investing Activities | -3.98 Million | 443.49 Thousand | 217.04 Million | 500.08 Million | 196.57 Million | 259.88 Million |
| Financing Cash Flow | -227.56 Million | 11.01 Million | -104.17 Million | -444.47 Million | -567.77 Million | -100.97 Million |
| Debt repayment | -44.49 Million | -440 Million | -77.42 Million | -628.54 Million | -740.49 Million | -643.31 Million |
| Dividends payments | -152.97 Million | -149.97 Million | -149.97 Million | -303.96 Million | -152.87 Million | -123.82 Million |
| Common Stock Repurchased | -30.09 Million | - | -193.5 Thousand | -303 Thousand | -309.51 Million | -28.41 Million |
| Common Stock Issuance | - | - | 193.5 Thousand | 171.83 Million | 309.51 Million | - |
| Other Financing Activities | 12.4 Million | 606.17 Million | 124.75 Million | 326.15 Million | 342.85 Million | 666.16 Million |
| Accounts receivables | 420.39 Million | -165.89 Million | 55.37 Million | 49.77 Million | -120.74 Million | -71.8 Million |
| Accounts payables | -50.62 Million | -83.13 Million | -86.65 Million | 82.56 Million | 28.81 Million | -13.85 Million |
| Inventory | -77.45 Million | -136.12 Million | -84.78 Million | -73.03 Million | -38.28 Thousand | -50.77 Million |
| Other working capital | 1.97 Million | 2.42 Million | 6.07 Million | -69.22 Million | -17.14 Million | -89.38 Million |
| Cash at beginning of period | 409.25 Million | 617.8 Million | 515.74 Million | 202 Million | 418.83 Million | 185.75 Million |
| Cash at end of period | 576.22 Million | 409.25 Million | 617.8 Million | 515.74 Million | 202 Million | 418.83 Million |
| Capital Expenditure | -100.33 Million | -70.98 Million | -90.37 Million | -62.53 Million | -100.67 Million | -103.53 Million |
| Effect of forex changes on cash | -1.59 Million | 41.88 Million | 7.38 Million | -18.59 Million | 4.36 Million | 17.85 Million |
| Net cash flow / Change in cash | 166.96 Million | -208.54 Million | 102.05 Million | 313.74 Million | -216.83 Million | 233.07 Million |
| Free Cash Flow | 428.61 Million | -142.46 Million | 13.18 Million | 254.74 Million | 60.86 Million | -78.08 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 126.79 Million | 78.68 Million | 104.1 Million | 181.86 Million | -15.99 Million | 78.82 Million |
| Depreciation & Amortization | - | 17.61 Million | 17.61 Million | 72.96 Million | 19.73 Million | -30.62 Million |
| Deferred income taxes | - | - | - | 10.51 Million | - | - |
| Stock-based compensation | - | - | - | 1.97 Million | 1.97 Million | - |
| Change in working capital | - | 81.29 Million | - | 292.31 Million | 344.91 Million | 32.9 Million |
| Other non-cash items | 41.83 Million | 50.06 Million | 69.05 Million | -175.09 Million | 173.15 Million | 202.5 Million |
| Investing Cash Flow | -75.32 Million | -64.27 Million | 81.08 Million | -134.02 Million | -25.46 Million | -5.82 Million |
| Investments in PPE | -12.05 Million | -15.15 Million | -7.74 Million | -100.33 Million | -52.7 Million | -18.68 Million |
| Acquisitions | - | - | 13.5 Million | 74.8 Million | 42.49 Million | 32.3 Million |
| Investment purchases | 76.18 Million | -76.18 Million | - | -266.3 Million | -266.3 Million | 224.37 Million |
| Sales/Maturities of investments | 392.18 Thousand | 100.34 Million | 2.05 Million | 157.8 Million | 157.8 Million | 251.64 Thousand |
| Other Investing Activities | -63.65 Million | -73.27 Million | 73.27 Million | -3.98 Million | 282.35 Million | -244.06 Million |
| Financing Cash Flow | 2.8 Million | -185.26 Million | -140.96 Million | -227.56 Million | -1.24 Million | -239.78 Million |
| Debt repayment | - | -35.48 Million | - | -44.49 Million | -35.5 Million | -280 Million |
| Dividends payments | -192.38 Thousand | -151.45 Million | -197.16 Thousand | -152.97 Million | -71.55 Thousand | -2.28 Million |
| Common Stock Repurchased | - | -140.77 Million | - | -30.09 Million | -42.5 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 3 Million | 140.96 Million | -140.77 Million | 12.4 Million | -36.75 Million | 42.5 Million |
| Accounts receivables | - | -64.68 Million | - | 420.39 Million | 420.39 Million | -195.68 Million |
| Accounts payables | - | - | - | -50.62 Million | - | - |
| Inventory | - | 145.97 Million | - | -77.45 Million | -77.45 Million | 228.59 Million |
| Other working capital | - | - | - | 1.97 Million | 1.97 Million | - |
| Cash at beginning of period | 546.18 Million | 684.24 Million | 575.01 Million | 409.25 Million | 464.69 Million | 425.16 Million |
| Cash at end of period | 637.45 Million | 546.18 Million | 684.24 Million | 576.22 Million | 576.22 Million | 464.69 Million |
| Capital Expenditure | -12.05 Million | -15.15 Million | -7.74 Million | -100.33 Million | -52.7 Million | -18.68 Million |
| Effect of forex changes on cash | -2.76 Million | 331.41 Thousand | -1.99 Million | -1.59 Million | -377.77 Thousand | 1.51 Million |
| Net cash flow / Change in cash | 91.27 Million | -138.06 Million | 109.22 Million | 166.96 Million | 111.53 Million | 39.52 Million |
| Free Cash Flow | 156.57 Million | 95.98 Million | 165.42 Million | 428.61 Million | 84.71 Million | 264.93 Million |
GNSMF
002164
001319
ALTR
EMSKF
CHEF